New journal helps practitioners prevent, diagnose and treat wide range of diseases

March 29, 2011

MELVILLE, N.Y. – March 21, 2011 – Henry Schein, Inc. (NASDAQ: HSIC), a provider of healthcare products and services to office-based practitioners, today announced the launch of its new clinical publication for medical practitioners. Designed to serve as a quick information source on the prevention, diagnosis and treatment of disease, the BioTherapeutics Quarterly Journal offers today’s medical practitioners a concise read on the latest trends in disease prevention and treatment.  Debuting in print last December, the Journal was published in February, and will subsequently be published in May, August and November, with an on-line version being introduced sometime in 2012.

The BioTherapeutics Quarterly Journal was conceived to highlight news on immunization practices, pharmaceutical interventions and diagnosis and treatment of disease.  Each issue features a New Drug Approvals section to keep medical professionals informed of the latest FDA-approved pharmaceuticals, drug shortages, disease outbreaks and other late-breaking news.

“In an age of technology that is chock-full of information, it can sometimes be overwhelming to quickly connect with the timely, reliable information.  The BioTherapeutics Quarterly Journal is designed to serve as a speedy read that delivers

relevant content to our customers. Our goal in producing this journal is to keep our

customers current on matters of prevention, diagnosis and treatment of disease,” said Louis Ferraro, Vice President and General Manager of BioTherapeutics for Henry Schein.

The new journal is the Company’s latest publication designed specifically for medical practitioners. Henry Schein also publishes the Xchange monthly e-newsletter for medical health care professionals. This electronic publication provides the latest information on the products and services that keep today’s practitioners abreast of important news and their practices operating successfully during changing economic times.  Henry Schein’s quarterly Privileges e-newsletter provides information on the latest practice-building techniques and tips to keep medical practitioners updated on all areas of running a successful practice.  These e-newsletters can be viewed by visiting: www.henryschein.com/xchangenewsetter or www.henryschein.com/privilegesmdnewsletter For more information about the BioTherapeutics Quarterly Journal, its advertising rates, or how to submit articles for consideration, please email [email protected].

Sponsored Recommendations

Patient Engagement and ML/AI – Modern Interoperability as an enabler for value based care

Discover how modern interoperability empowers patient engagement and leverages ML/AI for better outcomes in value-based care. Join us on June 18th to learn how seamless data integration...

The Crushing Weight of Healthcare Cloud Compliance & Security Debt: Perspectives & Strategies

Discover how to navigate the pressing challenges of healthcare cloud compliance and security. Join industry experts as they unveil key insights and actionable strategies to break...

Telehealth: Moving Forward Into the Future

Register now to explore two insightful sessions that delve into the transformative potential of telehealth and virtual care management solutions.

Telehealth: Moving Forward Into the Future

Register now to explore two insightful sessions that delve into the transformative potential of telehealth and virtual care management solutions.